Skip to main content

Heron Therapeutics, Inc. (NASDAQ: HRTX) Investor Securities Class Action Lawsuit 06/05/2019

  • If you purchased shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

November 21, 2019 - The case was voluntarily dismissed. June 5, 2019 - An investor in shares of Heron Therapeutics, Inc. (NASDAQ: HRTX) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Heron Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between October...



You must register (for free) or login to view the entire case.